![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Lloyds Banking Group Plc | LSE:LLOY | London | Ordinary Share | GB0008706128 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.02 | 0.03% | 60.66 | 60.36 | 60.38 | 60.52 | 59.54 | 59.82 | 141,047,083 | 16:35:08 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Commercial Banks, Nec | 23.74B | 5.46B | 0.0859 | 7.03 | 38.55B |
Date | Subject | Author | Discuss |
---|---|---|---|
19/3/2020 18:06 | Beeb wheeling out Gordon Brown phew think only if we still had all that gold .. | ![]() pal44 | |
19/3/2020 17:56 | CM - pleased to read that. ;) | ![]() alphorn | |
19/3/2020 17:55 | Minerve - really disappointed with your #273. You will just join the large majority on here and I shall then be alone. Lol | ![]() alphorn | |
19/3/2020 17:43 | I am on my last carrot today...shops open tomorrow?... | ![]() diku | |
19/3/2020 17:25 | My mum has been limited to 3 carrots, she wanted 6. LOL | ![]() minerve 2 | |
19/3/2020 17:19 | I have a feeling that a large amount of people have unknowingly had this Covid19 already. We need the test for antibodies ASAP. | ![]() chinahere | |
19/3/2020 17:06 | ALP,'re 205, I wish Michel Barnier a swift recovery,my thinking was purely that any comment on here can and will be misconstrued so I did not pursue that avenue. | ![]() cm44 | |
19/3/2020 16:55 | "ASDB919 Mar '20 - 16:08 - 297268 of 297284 Went to Tesco. Its ridiculous shelves empty. All i could get was 8 hair dryers and 4 barbaque sets" Give you two toilet rolls for 1 bbq set + 1 hairdryer. What kind are they | ![]() crossing_the_rubicon | |
19/3/2020 16:48 | No one has miss the bottom because we still at the bottom for a week now... and I see no news to move us higher from here.. no yet.Claims from the Trump administration about vaccine are false claims (like all other claims from aroundthe world) if they were close to find one Trump would be shouting from the rooftop of the white house. | k38 | |
19/3/2020 16:42 | Just looked, the pound against Euro made a reasonable come back from this morning's €1.0646. €1.090 now. Very much looks as if my holidays been cancelled on the 13th April so it dont matter much to me now. | ![]() chavitravi2 | |
19/3/2020 16:41 | Favipiravir works! Preliminary Clinical Studies Suggest Positive Effects on COVID-19 Patients Since the outbreak of COVID-19, people around the globe have been eagerly awaiting a real breakthrough on its treatment. Fortunately, a silver lining seems finally to be showing up. The virus clearance rate is a well-established golden standard assessing the clinical effectiveness of an antiviral medication. Recently, preliminary results of the “Clinical Study on Favipiravir’s Safety and Effectiveness to COVID-19 Patients” led by the Third People's Hospital of Shenzhen were released at a press conference held by the Ministry of Science and Technology of the P.R.C. In this study, it shows that Favipiravir alleviated the pneumonia symptom of COVID-19 patients with high tolerance and few adverse reactions, potentially through a mechanism that can quickly eliminate the coronaviruses from their bodies. Significant clinical differences have been observed between the 35-patient experimental group treated with Favipiravir and the 45-patient control group treated with Lopinavir / Ritonavir. The medians of the virus clearance time were 4 days (2.5 ~ 9 days) and 11 days (8 ~ 13 days), respectively (P < 0.001); the posttreatment fever-allaying rates within 2 days were 72.41% versus 26.30%; while the chest-imaging improvement rates were 91.43% versus 62.22%. Notably, the adverse reaction rates of Favipiravir-treated patients were merely 11.43%, comparing to a 55.56% in the control group. Another clinical trial led by the Zhongnan Hospital (Wuhan, China), with 120 COVID- 19 patients recruited in both experimental group(favipir (abidoleʌ significantly better than that in the control group, which was 71.43% and 55.86%, respectively. The same significant advantage went to the average antipyretic and cough remission time. | ![]() stonedyou | |
19/3/2020 16:37 | Hysteria all priced in to market now. If peeps miss the floor then thats their tough luck as the billions pour into the markets. The hype has been over the top. | ![]() cromw3ll | |
19/3/2020 16:36 | Stonedyou I personally i am not nervous. At this level all shares are excellent buys BUT we don't really know yet if this is the end of story.Keeping some cash in case... | k38 | |
19/3/2020 16:35 | Panic over, the yanks have got a fix. Sky news | ![]() maxk | |
19/3/2020 16:34 | well I got that wrong today! :) Lloyds price remarkably static at bout 33p regardless of the gyrations of the rest of the market. | ![]() ekuuleus | |
19/3/2020 16:26 | Come on you old Nag get back up. | ![]() y1phr1 | |
19/3/2020 16:25 | Quite right minerve, life is only what you make of it. | ![]() ladeside | |
19/3/2020 16:25 | I cashed out 3 weeks ago appart from 1 share | asdb9 | |
19/3/2020 16:16 | There will be lots more "happening", wait until the supply lines dry up (which they are already starting to due to container shortages and associated issues with Shipping). Wait until millions are paid off or ordered to take unpaid leave. Wait until a lockdown is ordered as it inevitably will be. Wait until we see a spike in deaths and our NHS unable to cope. All these things are a given and anarchy will ensue, it's going to happen, just a matter of how soon....... | ![]() ladeside | |
19/3/2020 16:12 | Hopefully not before the new tax year. I have some cgt profit to offset with some of the losses here. And as many shares as I can to b and b into Isa. Get nearly twice as many done this year. Every cloud 'n all. | ![]() 1carus |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions